CARBIDOPA, LEVODOPA AND ENTACAPONE 50 mg/1

Carbidopa, Levodopa, and Entacapone 50 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This oral treatment helps improve motor function and reduce tremors.

Carbidopa, Levodopa, and Entacapone 50 mg/1 tablets are primarily used to treat Parkinson's disease. The combination of these active ingredients works to increase dopamine levels in the brain, which helps alleviate symptoms such as stiffness, tremors, and difficulty moving. This medication is often prescribed to improve motor function and quality of life for individuals with Parkinson's disease.

Common effects of Carbidopa, Levodopa, and Entacapone 50 mg/1 tablets may include nausea, dizziness, and headache. Some users may also experience involuntary movements, insomnia, or changes in appetite. These effects can vary from person to person and may subside as the body adjusts to the medication.

It is important to handle Carbidopa, Levodopa, and Entacapone 50 mg/1 tablets with care. Store them in a cool, dry place away from direct sunlight and out of reach of children. Always follow the prescribed dosage and consult a healthcare provider before making any changes to your medication regimen.

Carbidopa, Levodopa, and Entacapone 50 mg/1 tablets may interact with other medications, including antidepressants, antipsychotics, and certain pain relievers. Alcohol consumption should be avoided as it can enhance the sedative effects of the medication. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.